Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Spitzmüller

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Cheminformatics|April 26, 2014
Identification of host interactions for phenotypic antimalarial hitsAndreas Spitzmüller, Jordi Mestres
Plos Computational Biology|October 23, 2013
Prediction of the P. falciparum target space relevant to malaria drug discoveryAndreas Spitzmüller, Jordi Mestres
Journal of Chemical Information and Modeling|May 3, 2011
MiniMuDS: a new optimizer using knowledge-based potentials improves scoring of docking solutionsAndreas Spitzmüller, Hans F G Velec, Gerhard Klebe
Plos One|August 30, 2017
MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancerAndreas Bösl, Andreas Spitzmüller, Zerina Jasarevic, et al.
Journal for Immunotherapy of Cancer|May 8, 2019
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapySonja Althammer, Tze Heng Tan, Andreas Spitzmüller, et al.
Scientific Reports|May 27, 2024
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancerAnsh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.
JCO Precision Oncology|May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric CancerAnsh Kapil, Henrik Failmezger, Yu Fu, et al.
Cancer Research Communications|December 18, 2025
Characterisation of the immunogenomic landscape of ovarian cancer uncovers a distinct subset of endometroid tumours associated with high CST2 expression and a favourable prognosisJames Boyle, Jan Zaucha, Felicia Ng, et al.
Plos Pathogens|July 29, 2016
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondWesley C Van Voorhis, John H Adams, Roberto Adelfio, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Cheminformatics|April 26, 2014
Identification of host interactions for phenotypic antimalarial hitsAndreas Spitzmüller, Jordi Mestres
Plos Computational Biology|October 23, 2013
Prediction of the P. falciparum target space relevant to malaria drug discoveryAndreas Spitzmüller, Jordi Mestres
Journal of Chemical Information and Modeling|May 3, 2011
MiniMuDS: a new optimizer using knowledge-based potentials improves scoring of docking solutionsAndreas Spitzmüller, Hans F G Velec, Gerhard Klebe
Plos One|August 30, 2017
MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancerAndreas Bösl, Andreas Spitzmüller, Zerina Jasarevic, et al.
Journal for Immunotherapy of Cancer|May 8, 2019
Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapySonja Althammer, Tze Heng Tan, Andreas Spitzmüller, et al.
Scientific Reports|May 27, 2024
HER2 quantitative continuous scoring for accurate patient selection in HER2 negative trastuzumab deruxtecan treated breast cancerAnsh Kapil, Andreas Spitzmüller, Nicolas Brieu, et al.
JCO Precision Oncology|May 28, 2026
Human Epidermal Growth Factor Receptor 2 Quantification Using Computational Pathology to Identify Novel Biomarkers for Trastuzumab Deruxtecan-Treated Human Epidermal Growth Factor Receptor 2-Positive Gastric CancerAnsh Kapil, Henrik Failmezger, Yu Fu, et al.
Cancer Research Communications|December 18, 2025
Characterisation of the immunogenomic landscape of ovarian cancer uncovers a distinct subset of endometroid tumours associated with high CST2 expression and a favourable prognosisJames Boyle, Jan Zaucha, Felicia Ng, et al.
Plos Pathogens|July 29, 2016
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and BeyondWesley C Van Voorhis, John H Adams, Roberto Adelfio, et al.
Pageof 1